Literature DB >> 1516277

Hematologic parameters and iron stores in patients on hemodialysis for chronic renal failure.

N Nuwayri-Salti1, F Jabre, M Daouk, G Sa'ab, Z Salem.   

Abstract

Thirty-two patients on hemodialysis for chronic renal failure were investigated. A correlation was sought between bone marrow iron stores assessed on Prussian-blue stained smears, and some common hematological parameters such as red blood corpuscle indexes obtained by coulter counter, serum iron, iron-binding capacity and serum ferritin levels (measured by RIA). MCH and MCV were both found significantly depressed in patients with depleted iron stores, a situation not reflected by any of the other tested parameters. These results reveal a practical and simple guideline for the treating practitioner who wants to initiate iron supplementation or withdrawal in these patients especially in areas where more elaborate tests may not be at hand.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516277

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients.

Authors:  Lillian A Rocha; Daniela V Barreto; Fellype C Barreto; Cristiane B Dias; Rosa Moysés; Maria Regina R Silva; Luiz A R Moura; Sérgio A Draibe; Vanda Jorgetti; Aluízio B Carvalho; Maria Eugênia F Canziani
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-08       Impact factor: 8.237

2.  Hepatic tuberculosis presenting with extreme hyperferritinemia masquerading as adult-onset Still's disease: a case report.

Authors:  Edirisooriya Maddumage Manoj; Rajini Srigrishna; Murugapillai K Ragunathan
Journal:  J Med Case Rep       Date:  2012-07-12

3.  Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.

Authors:  Kazuya Takasawa; Chikako Takaeda; Teiryo Maeda; Norishi Ueda
Journal:  Nutrients       Date:  2014-12-29       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.